Approximately 60 cancer survivors, caregivers and their families from across the state gathered in Topeka today to urge lawmakers to improve Kansans’ access to health care coverage and confront youth smoking rates.
SALT LAKE CITY—Today, the Utah Senate passed Senate Bill 96 that reverses the will of Utah voters and will undermine effective cancer prevention and treatment in the state.
WASHINGTON, D.C.– Christopher W. Hansen, President of the American Cancer Society Cancer Action Network (ACS CAN), released this statement following Tuesday’s election:
Virginia State Sen. Hanger received the National Distinguished Advocacy Award from the American Cancer Society Cancer Action Network in recognition of his dedication to expand access to health care.
South Carolina is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer.
North Carolina is falling short when it comes to implementing policies and passing legislation to prevent and reduce suffering and death from cancer.
State lawmakers across the country are missing important opportunities to pass and implement proven legislative solutions to prevent and fight cancer, according to a report released today by the American Cancer Society Cancer Action Network (ACS CAN). How Do You Measure Up?: A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality grades states on the strength of evidence-based policies that help to prevent cancer, which kills roughly 1,670 people a day nationwide, forces patients to pay nearly $4 billion in out-of-pocket expenses every year and in 2015 cost the country more than $80 billion in direct medical expenditures.
Today a federal judge ruled the Department of Health and Human Services (HHS) failed to adequately consider how Kentucky’s proposed Medicaid work rules would effect residents’ access to health care as required under federal law.
The Centers for Medicare and Medicaid Services (CMS) announced today that they will not approve Massachusetts’ request to restrict Medicaid prescription drug coverage to as few as one drug per class—a practice commonly called a “closed formulary”—unless a state foregoes all manufacturer rebates.
The Department of Justice (DOJ) announced last night it will not defend several critical patient protections in the health law and instead is arguing to end them. If successful, the case could leave millions of Americans with serious illnesses unable to obtain health care coverage.